Mass exodus in MS







So bad once people don't have to pay back their sign on bonus watch out. The division is run by primary care managers in a biotech arena. Gilenya could be a billion dollar drug but Novartis hired the wrong leaders.
 
























Leave it to noFArTus to screw up a sure winner like G.

The mass market care approach no longer works in primary care and never worked in specialty.

Oncology is also suffering from the likes of Volante and Company. Now that sales are drying up there watch out for falling Reps!
 






So bad once people don't have to pay back their sign on bonus watch out. The division is run by primary care managers in a biotech arena. Gilenya could be a billion dollar drug but Novartis hired the wrong leaders.

The fact is that the culture and promises made before hiring did not come true. They did not make the MS division different than the other NVS franchises. The experienced people from the biotech world are just disappointed it did not live up to expectations. Come Sept-Jan probably 50% of the Fall 2010 hires will look for another position. I would think 15%-20% will actually find one and leave. Just time to move on and a good lesson learned.
 












Hell if I lived in Mississippi, I would leave too!

???

Novartis is slowly crumbling from within. Pipeline is not performing and branded $billion products are soon to be generic. Management will put the pressure on the reps and goals increased to make it look like it's a problem with the field - including Regionals, managers and the reps.

It's going to be a heck of a ride!
 






???

Novartis is slowly crumbling from within. Pipeline is not performing and branded $billion products are soon to be generic. Management will put the pressure on the reps and goals increased to make it look like it's a problem with the field - including Regionals, managers and the reps.

It's going to be a heck of a ride!

just work!
 






CM is not a leader and has been demoted many times. Why do you think he is in MS because he was demoted excuse me promoted to this position due to Gender Lawsuit Outcome. He was a primary care manager in AR. He has been demoted more than one time. He has his entire family working for company. Good ole boys club! Sad
 






I can't figure out why they insisted on hiring so many reps with MS experience but don't allow us to use that experience. You can't say anything about it or you're a "complainer". Upper management is comprised of people who were next in line for promotions, not people with the experience to sell in this complicated market. They probably took the job just for their resume to move on quickly to the next level = uninvested in the results. Great drug, poorly run division. Just wait until Teva and Biogen show Novartis how a pill should really be marketed right out of the gate... sad.
 






I can't figure out why they insisted on hiring so many reps with MS experience but don't allow us to use that experience. You can't say anything about it or you're a "complainer". Upper management is comprised of people who were next in line for promotions, not people with the experience to sell in this complicated market. They probably took the job just for their resume to move on quickly to the next level = uninvested in the results. Great drug, poorly run division. Just wait until Teva and Biogen show Novartis how a pill should really be marketed right out of the gate... sad.

Rumor yesterday - if you were a new hire and are performing in bottom 1/3 as of 12/11, you will be replaced 1/12.
 
























Hell if I lived in Mississippi, I would leave too!

Gov. Barbour has ordered evacuations of the delta low lying area due to the extreme flooding that is taking place as the Mississippi River rises causing smaller creeks and rivers to not be able to drain. The Governor said "we are not going to be removing people (sorry a$$ lazy blacks) so you better get your a$$ out! This is not Katrina and I am not Ray Nagin so get your sorry black a$$e$ out now while you can"!
 






Novartis upper management has no idea what is to come when Buyogen launches BG12. They will see a company launch an oral with comparative marketing materials right out of the gate and a sales team that will stop at nothing to get business. Novartis MS newbies are about to get a rude awakening to the hostile MS market place. Bet you that Buy O Gen has more marketing info, data, etc. before Gilenya does....and we had a 1 year head start. I was around for Avonex and Tysabri launches and can tell you that the Gilenya launch has no comparisons. Buyogen would have fired the marketing team and upper management.
 






Novartis upper management has no idea what is to come when Buyogen launches BG12. They will see a company launch an oral with comparative marketing materials right out of the gate and a sales team that will stop at nothing to get business. Novartis MS newbies are about to get a rude awakening to the hostile MS market place. Bet you that Buy O Gen has more marketing info, data, etc. before Gilenya does....and we had a 1 year head start. I was around for Avonex and Tysabri launches and can tell you that the Gilenya launch has no comparisons. Buyogen would have fired the marketing team and upper management.[/


It's the compliance department that is running the company. They should of sold the drug to a biotech company. Upper management has no clue go back to primary care.